Today: 10 June 2026
Marvell stock rises today as Fed minutes loom — and a CES CEO chat is next
30 December 2025
2 mins read

Marvell stock rises today as Fed minutes loom — and a CES CEO chat is next

NEW YORK, December 30, 2025, 13:29 ET — Regular session

  • Marvell Technology shares rose about 1.1% in early afternoon trading, outpacing a flat-to-lower U.S. market.
  • Traders were positioning for the Federal Reserve’s December meeting minutes due at 2 p.m. ET, a key read for 2026 rate expectations.
  • The next company event on the calendar is a Jan. 6 CES fireside chat with CEO Matt Murphy, with Marvell pitching AI infrastructure interconnect and memory-link products.

Marvell Technology (MRVL) shares rose 1.1% to $86.74 in early afternoon trading on Tuesday, after swinging between $85.58 and $88.07.

The move matters because Marvell sits in the center of spending on AI data centers, an area where budgets and valuations tend to react quickly when interest-rate expectations shift. Traders were also bracing for thin, year-end liquidity, which can amplify intraday moves.

Investors also have a near-term company catalyst: a Jan. 6 CES fireside chat hosted by J.P. Morgan with Marvell CEO Matt Murphy, the company’s investor relations calendar shows. Marvell says it will use CES to show products aimed at “accelerated infrastructure,” including copper and optical interconnects and CXL, a standard used to link processors, accelerators and memory in servers. Marvell Technology, Inc.+1

The broader market was subdued. The S&P 500 and Nasdaq were slightly lower around midday as gains in some sectors were capped by softness in technology and financials, Reuters reported.

The valuation gap is so wide, it absolutely is justified to see repositioning,” said Mark Hackett, chief market strategist at Nationwide, describing the recent rotation inside U.S. equities. Reuters

Chip shares were mixed. Broadcom was up about 0.6% while Nvidia and AMD were fractionally lower, with semiconductor ETFs edging higher.

Macro focus was on the Federal Reserve. Minutes from the Fed’s Dec. 9–10 meeting are due at 2 p.m. ET; minutes are the detailed record of policymakers’ discussion and often reset expectations for the path of interest rates.

The December meeting delivered a quarter-point cut that took the fed funds target range to 3.50%–3.75% and drew three dissents, Reuters reported, underscoring divisions inside the committee about how to balance inflation risks against a weakening labor picture.

For Marvell, the rate backdrop matters because high-growth semiconductor names tend to trade off changes in discount rates, and because its biggest customers are large cloud companies that can adjust capital spending quickly. Reuters flagged holiday-thin trading conditions as a factor that can heighten volatility into year-end.

On the company side, Marvell is positioning itself deeper into next-generation AI infrastructure. Earlier this month it agreed to buy photonics startup Celestial AI for $3.25 billion to bolster work in silicon photonics — using light rather than electrical signals to move data faster and more efficiently inside data centers — with the deal expected to close in the first quarter of 2026.

That push puts Marvell into closer competition with larger AI infrastructure suppliers, including Nvidia and Broadcom, in areas such as interconnect and custom silicon designed for specific cloud customers.

What investors are watching next: the Fed minutes at 2 p.m. ET for any shift in the “higher bar” for more rate cuts in 2026, and Wednesday’s lean U.S. data slate led by weekly jobless claims and the S&P Case-Shiller home price index, alongside year-end market schedules. MarketWatch+1

Stock Market Today

  • Palantir Technologies (PLTR) Shares Seen Fairly Valued Amid Recent Decline
    June 10, 2026, 5:48 PM EDT. Palantir Technologies has seen its share price fall 13.2% over the past week and 21.3% year to date, following extraordinary gains in prior years. At $132.07 per share, Palantir trades slightly below its estimated intrinsic value of $145.11 based on a Discounted Cash Flow (DCF) analysis, suggesting a modest 9% discount. The company posted $2.69 billion in free cash flow over the past twelve months, with projections rising to $16.11 billion by 2030. Despite recent volatility tied to sentiment on artificial intelligence and software spending, Palantir remains fairly valued but not a clear bargain. Investors should monitor further market developments and valuation metrics to gauge future opportunities or risks.

Latest articles

Parabilis Medicines (PBLS) soars 58% after $670 million IPO beats range

Parabilis Medicines (PBLS) soars 58% after $670 million IPO beats range

10 June 2026
Parabilis Medicines soared 58% above its $20 IPO price to close at $31.60 in its Nasdaq debut after raising a record $670 million, reflecting strong investor demand for its Helicon drug platform ahead of a pivotal Phase 3 desmoid tumor trial planned for 2027; Regeneron’s $75 million private placement added credibility.
Joby Aviation Shares Slip After CFO Files to Sell Stock

Joby Aviation Shares Slip After CFO Files to Sell Stock

10 June 2026
Joby Aviation fell 4.47% to $8.86 after CFO Rodrigo Brumana disclosed selling 78,489 shares under a prearranged 10b5-1 plan, with no new certification or commercial-launch updates, leaving investors focused on regulatory progress and cash burn as the key catalysts for the stock.
YY Group Shares Spike as Humanoid Robot Plans Unveiled

YY Group Shares Spike as Humanoid Robot Plans Unveiled

10 June 2026
YY Group Holding shares surged to $0.165 on heavy volume after announcing a commercial humanoid-robotics initiative using Unitree G1 robots and facility-management data, reframing the company as a robotics-and-AI data play; the rally comes despite 2025 net loss, dilution risk from a relaunched at-the-market share-sale program, and no disclosed robot-related revenue or contracts.
SELLAS Life Sciences (SLS) stock jumps on Phase 3 AML trial timing update — what investors watch next
Previous Story

SELLAS Life Sciences (SLS) stock jumps on Phase 3 AML trial timing update — what investors watch next

Nvidia stock dips after AI21 Labs talk report as NVDA investors size up Intel stake
Next Story

Nvidia stock dips after AI21 Labs talk report as NVDA investors size up Intel stake

Go toTop